{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:36:47Z","timestamp":1787960207231,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40256-020-00447-5","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T01:02:13Z","timestamp":1612400533000},"page":"471-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-8773","authenticated-orcid":false,"given":"Yong","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Van de Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Rossello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Tang","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.-L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"4","key":"447_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3349\/ymj.2009.50.4.537","volume":"50","author":"YU Kang","year":"2009","unstructured":"Kang YU, Jeong MH, Kim SW. Impact of renal dysfunction on clinical outcomes of acute coronary syndrome. Yonsei Med J. 2009;50(4):537\u201345.","journal-title":"Yonsei Med J."},{"issue":"12","key":"447_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIR.0000000000000183","volume":"131","author":"JB Washam","year":"2015","unstructured":"Washam JB, Herzog CA, Beitelshees AL, Cohen MG, Henry TD, Kapur NK, et al. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. Circulation. 2015;131(12):1123\u201349.","journal-title":"Circulation"},{"issue":"2","key":"447_CR3","first-page":"132","volume":"29","author":"CC Huang","year":"2013","unstructured":"Huang CC, Chen JW. Contemporary management of coronary artery disease and acute coronary syndrome in patients with chronic kidney disease and end-stage renal disease. Acta Cardiol Sin. 2013;29(2):132\u201341.","journal-title":"Acta Cardiol Sin."},{"issue":"3","key":"447_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"CS Fox","year":"2010","unstructured":"Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010;121(3):357\u201365.","journal-title":"Circulation"},{"issue":"10","key":"447_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/archinternmed.2010.95","volume":"170","author":"I Goldenberg","year":"2010","unstructured":"Goldenberg I, Subirana I, Boyko V, Vila J, Elosua R, Permanyer-Miralda G, et al. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. Arch Intern Med. 2010;170(10):888\u201395.","journal-title":"Arch Intern Med."},{"issue":"6","key":"447_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jjcc.2012.08.007","volume":"60","author":"T Dohi","year":"2012","unstructured":"Dohi T, Kasai T, Miyauchi K, Takasu K, Kajimoto K, Kubota N, et al. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome. J Cardiol. 2012;60(6):438\u201342.","journal-title":"J Cardiol."},{"key":"447_CR7","doi-asserted-by":"publisher","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575","DOI":"10.1093\/eurheartj\/ehaa575"},{"issue":"2","key":"447_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J."},{"issue":"22","key":"447_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2011.08.051","volume":"58","author":"SS Basra","year":"2011","unstructured":"Basra SS, Tsai P, Lakkis NM. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. J Am Coll Cardiol. 2011;58(22):2263\u20139.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"447_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00392-018-1378-0","volume":"108","author":"X Rossello","year":"2019","unstructured":"Rossello X, Ariti C, Pocock SJ, Ferreira JP, Girerd N, McMurray JJV, et al. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials. Clin Res Cardiol. 2019;108(5):477\u201386.","journal-title":"Clin Res Cardiol."},{"issue":"4","key":"447_CR11","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1016\/j.ijcard.2013.06.013","volume":"168","author":"HD Huang","year":"2013","unstructured":"Huang HD, Alam M, Hamzeh I, Virani S, Deswal A, Aguilar D, et al. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013;168(4):3741\u20136.","journal-title":"Int J Cardiol."},{"issue":"5","key":"447_CR12","doi-asserted-by":"publisher","first-page":"e0153478","DOI":"10.1371\/journal.pone.0153478","volume":"11","author":"C Shaw","year":"2016","unstructured":"Shaw C, Nitsch D, Lee J, Fogarty D, Sharpe CC. Impact of an early invasive strategy versus conservative strategy for unstable angina and non-ST elevation acute coronary syndrome in patients with chronic kidney disease: a systematic review. PLoS ONE. 2016;11(5):e0153478.","journal-title":"PLoS ONE"},{"issue":"10","key":"447_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"K Szummer","year":"2009","unstructured":"Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009;120(10):851\u20138.","journal-title":"Circulation"},{"issue":"1","key":"447_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.kint.2016.09.014","volume":"91","author":"JJ Carrero","year":"2017","unstructured":"Carrero JJ, Varenhorst C, Jensevik K, Szummer K, Lagerqvist B, Evans M, et al. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease. Kidney Int. 2017;91(1):216\u201326.","journal-title":"Kidney Int."},{"issue":"4","key":"447_CR15","first-page":"329","volume":"33","author":"CY Chu","year":"2017","unstructured":"Chu CY, Lin TH, Lai WT. The management and prognostic factors of acute coronary syndrome: evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry. Acta Cardiol Sin. 2017;33(4):329\u201338.","journal-title":"Acta Cardiol Sin."},{"issue":"6","key":"447_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/clc.22253","volume":"37","author":"JW Rhee","year":"2014","unstructured":"Rhee JW, Wiviott SD, Scirica BM, Gibson CM, Murphy SA, Bonaca MP, et al. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin Cardiol. 2014;37(6):350\u20136.","journal-title":"Clin Cardiol."},{"issue":"7","key":"447_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/2047487317693950","volume":"24","author":"M Khedri","year":"2017","unstructured":"Khedri M, Szummer K, Carrero JJ, Jernberg T, Evans M, Jacobson SH, et al. Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function. Eur J Prev Cardiol. 2017;24(7):724\u201334.","journal-title":"Eur J Prev Cardiol."},{"issue":"3","key":"447_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000455239","volume":"7","author":"Z Rozenbaum","year":"2017","unstructured":"Rozenbaum Z, Benchetrit S, Minha S, Neuman Y, Shlezinger M, Goldenberg I, et al. The effect of admission renal function on the treatment and outcome of patients with acute coronary syndrome. Cardiorenal Med. 2017;7(3):169\u201378.","journal-title":"Cardiorenal Med."},{"issue":"1","key":"447_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/clc.23116","volume":"42","author":"X Rossello","year":"2019","unstructured":"Rossello X, Bueno H, Pocock SJ, Van de Werf F, Danchin N, Annemans L, et al. Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: results from the EPICOR registry. Clin Cardiol. 2019;42(1):111\u20139.","journal-title":"Clin Cardiol."},{"issue":"1","key":"447_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ahj.2012.10.018","volume":"165","author":"H Bueno","year":"2013","unstructured":"Bueno H, Danchin N, Tafalla M, Bernaud C, Annemans L, Van de Werf F. EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics. Am Heart J. 2013;165(1):8\u201314.","journal-title":"Am Heart J."},{"issue":"9","key":"447_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/clc.22431","volume":"38","author":"Y Huo","year":"2015","unstructured":"Huo Y, Lee SWL, Sawhney JPS, Kim H-S, Krittayaphong R, Nhan VT, et al. Rationale, design, and baseline characteristics of the EPICOR Asia study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia). Clin Cardiol. 2015;38(9):511\u20139.","journal-title":"Clin Cardiol."},{"issue":"9","key":"447_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1515\/CCLM.2009.263","volume":"47","author":"AA Soares","year":"2009","unstructured":"Soares AA, Eyff TF, Campani RB, Ritter L, Camargo JL, Silveiro SP. Glomerular filtration rate measurement and prediction equations. Clin Chem Lab Med. 2009;47(9):1023\u201332.","journal-title":"Clin Chem Lab Med."},{"issue":"9","key":"447_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jacc.2003.06.001","volume":"42","author":"CM Gibson","year":"2003","unstructured":"Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003;42(9):1535\u201343.","journal-title":"J Am Coll Cardiol."},{"issue":"13","key":"447_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285\u201395.","journal-title":"N Engl J Med."},{"issue":"9","key":"447_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","volume":"89","author":"JJ Santopinto","year":"2003","unstructured":"Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89(9):1003\u20138.","journal-title":"Heart"},{"issue":"9","key":"447_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1253\/circj.CJ-08-0088","volume":"72","author":"SH Lee","year":"2008","unstructured":"Lee SH, Kim YJ, Kim W, Park JS, Shin DG, Hur SH, et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J. 2008;72(9):1410\u20138.","journal-title":"Circ J."},{"key":"447_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2017.07.039","volume":"245","author":"X Rossello","year":"2017","unstructured":"Rossello X, Huo Y, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol. 2017;245:27\u201334.","journal-title":"Int J Cardiol."},{"issue":"9","key":"447_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00392-018-1254-y","volume":"107","author":"H Bueno","year":"2018","unstructured":"Bueno H, Rossello X, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome. Clin Res Cardiol. 2018;107(9):836\u201344.","journal-title":"Clin Res Cardiol."},{"issue":"11","key":"447_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIR.0000000000000336","volume":"133","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC\/AHA\/SCAI Focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI Guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA Guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133(11):1135\u201347.","journal-title":"Circulation"},{"issue":"4","key":"447_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacc.2012.11.018","volume":"61","author":"PT O'Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF\/AHA Guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;61(4):485\u2013510.","journal-title":"J Am Coll Cardiol."},{"issue":"10","key":"447_CR31","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1055\/s-0038-1669426","volume":"118","author":"L Bonello","year":"2018","unstructured":"Bonello L, Laine M, Lemesle G, Puymirat E, Dabry T, Thuny F, et al. Meta-analysis of potent P2Y12-ADP receptor antagonist therapy compared to clopidogrel therapy in acute coronary syndrome patients with chronic kidney disease. Thromb Haemost. 2018;118(10):1839\u201346.","journal-title":"Thromb Haemost."},{"issue":"15","key":"447_CR32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1161\/CIRCULATIONAHA.118.032078","volume":"138","author":"L Bonello","year":"2018","unstructured":"Bonello L, Angiolillo DJ, Aradi D, Sibbing D. P2Y(12)-ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes. Circulation. 2018;138(15):1582\u201396.","journal-title":"Circulation"},{"issue":"25","key":"447_CR33","first-page":"e344","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA\/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circulation. 2014;130(25):e344\u2013426.","journal-title":"Circulation"},{"issue":"11","key":"447_CR34","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","volume":"122","author":"S James","year":"2010","unstructured":"James S, Budaj A, Aylward P, Buck KK, Cannon CP, Cornel JH, et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2010;122(11):1056\u201367.","journal-title":"Circulation"},{"issue":"6","key":"447_CR35","doi-asserted-by":"publisher","first-page":"e011139","DOI":"10.1161\/JAHA.118.011139","volume":"8","author":"F Franchi","year":"2019","unstructured":"Franchi F, James SK, Ghukasyan Lakic T, Budaj AJ, Cornel JH, Katus HA, et al. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial. J Am Heart Assoc. 2019;8(6):e011139.","journal-title":"J Am Heart Assoc."},{"issue":"10","key":"447_CR36","doi-asserted-by":"publisher","first-page":"e012236","DOI":"10.1161\/JAHA.119.012236","volume":"8","author":"JA Rymer","year":"2019","unstructured":"Rymer JA, Kaltenbach LA, Doll JA, Messenger JC, Peterson ED, Wang TY. Safety of dual-antiplatelet therapy after myocardial infarction among patients with chronic kidney disease. J Am Heart Assoc. 2019;8(10):e012236.","journal-title":"J Am Heart Assoc."},{"issue":"9","key":"447_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/clc.23400","volume":"43","author":"B Zheng","year":"2020","unstructured":"Zheng B, Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, et al. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study. Clin Cardiol. 2020;43(9):999\u20131008.","journal-title":"Clin Cardiol."},{"issue":"2","key":"447_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/heartjnl-2016-309509","volume":"103","author":"H Bueno","year":"2017","unstructured":"Bueno H, Pocock S, Danchin N, Annemans L, Gregson J, Medina J, et al. International patterns of dual antiplatelet therapy duration after acute coronary syndromes. Heart. 2017;103(2):132\u20138.","journal-title":"Heart"},{"key":"447_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2020.01.008","volume":"310","author":"S Zhang","year":"2020","unstructured":"Zhang S, Wang W, Sawhney JPS, Krittayaphong R, Kim HS, Nhan VT, et al. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. Int J Cardiol. 2020;310:16\u201322.","journal-title":"Int J Cardiol."},{"issue":"4","key":"447_CR40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/clc.23322","volume":"43","author":"Y Zou","year":"2020","unstructured":"Zou Y, Yang S, Wang S, Lv B, Xiu L, Li L, et al. Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia. Clin Cardiol. 2020;43(4):346\u201354.","journal-title":"Clin Cardiol."},{"key":"447_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2020.05.022","volume":"315","author":"Y Huo","year":"2020","unstructured":"Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, et al. Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: findings from the EPICOR Asia study. Int J Cardiol. 2020;315:1\u20138.","journal-title":"Int J Cardiol."},{"issue":"1","key":"447_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0366-6999.147330","volume":"128","author":"C Li","year":"2015","unstructured":"Li C, Hu D, Shi X, Li L, Yang J, Song L, et al. A multicentre prospective evaluation of the impact of renal insufficiency on in-hospital and long-term mortality of patients with acute ST-elevation myocardial infarction. Chin Med J (Engl). 2015;128(1):1\u20136.","journal-title":"Chin Med J (Engl)."},{"issue":"5","key":"447_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00380-018-1291-5","volume":"34","author":"K Otsuka","year":"2019","unstructured":"Otsuka K, Shimada K, Katayama H, Nakamura H, Ishikawa H, Takeda H, et al. Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention. Heart Vessels. 2019;34(5):735\u201344.","journal-title":"Heart Vessels."},{"issue":"33","key":"447_CR44","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/eurheartj\/ehaa277","volume":"41","author":"TF L\u00fcscher","year":"2020","unstructured":"L\u00fcscher TF, Miller VM, Bairey Merz CN, Crea F. Diversity is richness: why data reporting according to sex, age, and ethnicity matters. Eur Heart J. 2020;41(33):3117\u201321.","journal-title":"Eur Heart J."},{"issue":"3","key":"447_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/2048872614551544","volume":"4","author":"PR Sinnaeve","year":"2015","unstructured":"Sinnaeve PR, Zeymer U, Bueno H, Danchin N, Medina J, Sanchez-Covisa J, et al. Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study. Eur Heart J Acute Cardiovasc Care. 2015;4(3):254\u201362.","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"issue":"1","key":"447_CR46","doi-asserted-by":"publisher","first-page":"e000347","DOI":"10.1136\/openhrt-2015-000347","volume":"3","author":"L Annemans","year":"2016","unstructured":"Annemans L, Danchin N, Van de Werf F, Pocock S, Licour M, Medina J, et al. Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry. Open Heart. 2016;3(1):e000347.","journal-title":"Open Heart."},{"issue":"1","key":"447_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.recesp.2015.08.019","volume":"69","author":"H Bueno","year":"2016","unstructured":"Bueno H, Martin AR. Long-term cardiovascular risk after acute coronary syndrome, an ongoing challenge. Rev Esp Cardiol (Engl Ed). 2016;69(1):1\u20132.","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"issue":"1","key":"447_CR48","first-page":"522","volume":"4","author":"TK Ong","year":"2016","unstructured":"Ong TK, Lee SW-L, Sawhney JPS, Kim H-S, Krittayaphong R, Nhan VT, et al. Management of acute coronary syndrome and the importance of hospital access: findings from the EPICOR Asia study. Eur. J Cardiovasc Med. 2016;4(1):522\u201330.","journal-title":"J Cardiovasc Med."},{"key":"447_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2017.04.059","volume":"243","author":"CT Chin","year":"2017","unstructured":"Chin CT, Ong TK, Krittayaphong R, Lee SW, Sawhney JPS, Kim HS, et al. Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: insights from the multinational EPICOR Asia study. Int J Cardiol. 2017;243:15\u201320.","journal-title":"Int J Cardiol."},{"issue":"3","key":"447_CR50","first-page":"193","volume":"94","author":"S Jan","year":"2016","unstructured":"Jan S, Lee SW, Sawhney JP, Ong TK, Chin CT, Kim HS, et al. Catastrophic health expenditure on acute coronary events in Asia: a prospective study. Bull WHO. 2016;94(3):193\u2013200.","journal-title":"Bull WHO."},{"issue":"11","key":"447_CR51","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2019.06.068","volume":"74","author":"H Bueno","year":"2019","unstructured":"Bueno H, Rossello X, Pocock SJ, Van de Werf F, Chin CT, Danchin N, et al. In-hospital coronary revascularization rates and post-discharge mortality risk in non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2019;74(11):1454\u201361.","journal-title":"J Am Coll Cardiol."},{"key":"447_CR52","doi-asserted-by":"publisher","unstructured":"Rossello X, Medina J, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking. Eur Heart J Acute Cardiovasc Care. 2020. https:\/\/doi.org\/10.1177\/2048872620911853","DOI":"10.1177\/2048872620911853"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00447-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-020-00447-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00447-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T23:04:47Z","timestamp":1674947087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-020-00447-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s40256-020-00447-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"16 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EPICOR and EPICOR Asia were funded by AstraZeneca. As they were noninterventional studies, no drugs were supplied or funded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"F. Van de Werf has received consulting fees and research grants from Boehringer Ingelheim and Merck and consulting fees from Roche, Sanofi-Aventis, AstraZeneca, and The Medicines Company. S.J. Pocock has received research funding from AstraZeneca. C.T. Chin has received research support from Eli Lilly and honoraria from Medtronic and has been a consultant or advisory board member for AstraZeneca. A.M. Vega is a former employee of AstraZeneca. J. Medina is an employee of AstraZeneca. H. Bueno receives research funding from the Instituto de Salud Carlos III, Spain (PIE16\/00021 and PI17\/01799), Sociedad Espa\u00f1ola de Cardiolog\u00eda, AstraZeneca, Bayer, BMS, and Novartis; has received consulting fees from AstraZeneca, Bayer, BMS-Pfizer, and Novartis; and speaking fees or support for attending scientific meetings from Amgen, AstraZeneca, Bayer, BMS-Pfizer, Novartis, and MEDSCAPE-the heart.org. X. Rossello has received support from the SEC-CNIC CARDIOJOVEN fellowship program. Y. Huo, Y. Han, S. W.-L. Lee, Y. Li, and J. Jiang have no conflicts of interest that are directly relevant to the content of this article. AstraZeneca reviewed the manuscript during development and could make suggestions; however, final content, opinions, conclusions, and interpretation of the data are the responsibility of the authors. Professor Huo had full access to all of the data in the studies and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca\u2019s data sharing policy described at https:\/\/astrazenecagrouptrials.pharmacm.com\/ST\/Submission\/Disclosure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"In both EPICOR and EPICOR Asia, the final study protocol was approved by the ethics committees of participating centers according to local regulations. The studies were performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent at discharge from hospital and completed a contact order form agreeing to be contacted by telephone for regular follow-up interviews post discharge.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"Conceptualization: Yong Huo, H\u00e9ctor Bueno, Stuart Pocock, and Ana Maria Vega (equal). Formal analysis: Stuart Pocock and Richard Cairns of Worldwide Clinical Trials (equal). Funding acquisition: Ana Maria Vega and Jes\u00fas Medina (equal). Investigation: Yong Huo, Frans Van de Werf, Yaling Han, Xavier Rossello, Chee Tang Chin, Stephen W-L Lee, Yi Li, Jie Jiang, and H\u00e9ctor Bueno (equal). Methodology: Yong Huo, H\u00e9ctor Bueno, Stuart Pocock, Ana Maria Vega, and Jes\u00fas Medina (equal). Project administration: Yong Huo and H\u00e9ctor Bueno (equal). Resources: Ana Maria Vega and Jes\u00fas Medina (equal). Supervision: Yong Huo and H\u00e9ctor Bueno (equal). Validation: Yong Huo, H\u00e9ctor Bueno, and Stuart Pocock (equal). Visualization: Yong Huo, H\u00e9ctor Bueno, and Stuart Pocock (equal). Writing \u2013 original draft: Yong Huo, H\u00e9ctor Bueno, Stuart Pocock, and Xavier Rossello (equal). Writing \u2013 review and editing: All authors (equal).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The authors thank Richard Cairns of Worldwide Clinical Trials (Nottingham, UK) for statistical analysis. Editorial support was provided by Carl V Felton PhD of Prime Global (Knutsford, Cheshire, UK), according to Good Publication Practice guidelines, and was funded by AstraZeneca.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}}]}}